LSB Industries LXU 深 沪
等待开盘 09-02 09:30:00 美东时间
11.18
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.18
- 总市值 8.05亿
- 52周最高 17.215
- 市盈率 静 32.87
- 换手率 0.00%
- 52周最低 7.71
- 委 比 0.00%
- 总股本 7199.75万
- 历史最高 36.4077
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.7692
- 每 手 1
- 风险率 2.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
RBC Capital Upgrades LSB Industries to Outperform, Maintains Price Target to $13
RBC Capital analyst Andrew D. Wong upgrades LSB Industries (NYSE:LXU) from Sector Perform to Outperform and maintains the price target from $13 to $13.
08-10 23:43
LSB Industries Bets on Turnarounds and CCS Growth
Lsb Industries, Inc. (($LXU)) has held its Q2 earnings call. Read on for the ma...
08-03 08:17
美股大行评级 | 台积电、联合健康、美国合众银行获多家大行上调目标价；奈飞、直觉外科遭数十家大行下调目标价
今日重点评级关注：摩根大通：维持联合大陆航空"超配"评级，目标价从156美元升至203美元；摩根士丹利：维持联合大陆航空"超配"评级，目标价从185美元升至190美元
07-20 13:49
RBC Capital Maintains Sector Perform on LSB Industries, Lowers Price Target to $13
RBC Capital analyst Andrew D. Wong maintains LSB Industries (NYSE:LXU) with a Sector Perform and lowers the price target from $15 to $13.
07-18 00:47
LSB Industries To Immediately Begin Planned Turnaround Of Pryor, Oklahoma Facility Initially Planned To Begin In July; Expects Timing Of Turnaround To Have No Impact On Expected Duration Or Cost Estimates
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000060714/000119312526251573/lxu-20260528.htm
06-02 04:39
LSB Industries Agrees With With Lapis Carbon Solutions On A Strategic Pathway To Take Full Ownership Of Arkansas Carbon Capture And Sequestration Asset Project Blue
Key Transaction Details:LSB Industries to acquire 100% ownership and control of the El Dorado CCS projectNo upfront cash payment required at closingInvestment to be made in stages tied to key milestones, with
05-19 20:40
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
RBC Capital Maintains Sector Perform on LSB Industries, Raises Price Target to $15
RBC Capital analyst Andrew D. Wong maintains LSB Industries (NYSE:LXU) with a Sector Perform and raises the price target from $14 to $15.
05-11 23:39
